MapLight Therapeutics is a clinical-stage biopharma focused on CNS disorders and has filed for a $100M U.S. IPO to fund its pipeline. Read why MPLT is a Hold.

TD Cowen analyst David Kwan said on Sept. 25 that the recent sell-off in Constellation Software ( Constellation Software Stock Quote, Chart, News, Analysts, Financials TSX:CSU) shares on concerns ...

Prosus N.V. is rated Buy. PROSF stock saw strong Tencent growth, NAV discount, and profitable e-commerce drives value. See more here.

The loyalty that Thinky’s employees have to Murati has also attracted investors. When she left OpenAI, where Murati had a storied career as its chief technology officer, 20 OpenAI staffers initially ...

In this podcast featuring Motley Fool analysts Tim Beyers and Rick Munarriz, topics include: DocuSign's prospects, and if now is the time to buy? The Big Macro and resilient industries. Fakers and ...

Meanwhile, yesterday’s packed events in New York overshadowed a clear warning Geroulanos gave to Androulakis. “If the needle (he meant the polls) doesn’t move upward in the next two months, we’ll have ...

CHICAGO (AP) — When it comes to his plans for the Chicago Blackhawks, general manager Kyle Davidson is focused on the growth and maturation of the organization's top prospects. That group includes a ...

The private equity owners of real estate software provider MRI Software are exploring options for the company, including a potential sale or a public listing on a U.S. exchange, according to people ...

Alternative IQ today announced the Top Contenders for the 2025 Canadian Hedge Fund Awards, the highest honour in Canada's hedge fund industry. Winners will be announced on Tuesday, October 28th at the ...

Investors looking at housing and homebuilders are probably wondering what to make of the seemingly contradictory messages out of the housing market.

S tock Market on 25 September 2025 | Share Market Updates - Find here all the updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets.

Indian equities fell for the fourth straight session on Wednesday, their longest losing run since mid-July, as worries over U.S. visa curbs continued to pressure sentiment. The BSE Sensex dropped 386 ...